Physician profile
Ryan Bakke
NPI 1225030406
$2,820.31
in general payments reported to CMS, 2019-2025
32 companies · $999 in 2025
The $999 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.43 · 2021: $280 · 2022: $182 · 2023: $644 · 2024: $703 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $611.94 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $430.17 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $235.31 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $202.39 | 2024-2025 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.28 | 2021-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.96 | 2021-2025 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $136.96 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.00 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $74.64 | 2023-2024 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $68.91 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $58.72 | 2023-2024 | Gardasil 9, Vaxneuvance, Belsomra |
| Amgen INC. | $56.79 | 2021-2022 | |
| Astellas Pharma US INC | $50.37 | 2020-2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $48.32 | 2021-2025 | Trintellix |
| Glaxosmithkline, LLC. | $46.02 | 2025 | Shingrix, Bexsero, Arexvy |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37.69 | 2021-2024 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $37.07 | 2025 | Voquezna |
| Biohaven Pharmaceuticals, INC. | $31.98 | 2021 | |
| Axsome Therapeutics, INC. | $29.09 | 2023-2024 | Auvelity |
| Abbott Laboratories | $20.91 | 2025 | Freestyle Libre 3 |
| Bausch & Lomb Americas INC. | $19.28 | 2023 | Vyzulta |
| Sanofi Pasteur INC. | $19.05 | 2023 | |
| Exact Sciences Corporation | $18.78 | 2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $18.76 | 2024 | Doc Band |
| Biohaven Pharmaceutical Holding Company LTD. | $17.86 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.99 | 2025 | Keveyis |
| Sanofi-Aventis U.S. LLC | $16.48 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.77 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.59 | 2024 | |
| Ardelyx, INC. | $14.25 | 2024 | Ibsrela |
| Janssen Pharmaceuticals, INC | $14.05 | 2021 | |
| Nabriva Therapeutics, Plc | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bakke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.